These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3298096)
1. Synthesis of conjugates between luteinizing hormone releasing hormone (LH-RH) and N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) models of totally synthetic vaccines. Bernard JM; Gras-Masse H; Drobecq H; Tartar A; Lefrancier P; Hosmalin A; Carelli C; Chedid L Int J Pept Protein Res; 1987 Apr; 29(4):455-63. PubMed ID: 3298096 [TBL] [Abstract][Full Text] [Related]
2. Immunological castration by a totally synthetic vaccine: modification of biological properties of LH-RH after conjugation to adjuvant-active muramyl peptide. Carelli C; Ralamboranto L; Audibert F; Gaillard J; Briquelet N; Dray F; Fafeur V; Haour F; Chedid L Int J Immunopharmacol; 1985; 7(2):215-24. PubMed ID: 3891644 [TBL] [Abstract][Full Text] [Related]
3. [Use of muramyl dipeptides in models of synthetic vaccines]. Audibert F Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261 [TBL] [Abstract][Full Text] [Related]
4. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the antigenic relationship of various derivatives of n-acetyl-muramyl-l-ala-d-isoglutamine (MDP), using anti-MDP antibodies. Bahr GM; Carelli C; Audibert F; Modabber F; Chedid L Mol Immunol; 1982 May; 19(5):737-45. PubMed ID: 7110143 [TBL] [Abstract][Full Text] [Related]
6. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine). Mozes E; Sela M; Chedid L Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530 [TBL] [Abstract][Full Text] [Related]
7. Immunological castration of male mice by a totally synthetic vaccine administered in saline. Carelli C; Audibert F; Gaillard J; Chedid L Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5392-5. PubMed ID: 6752946 [TBL] [Abstract][Full Text] [Related]
8. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions. Souvannavong V; Adam A Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138 [TBL] [Abstract][Full Text] [Related]
9. Decrease in pyrogenicity of muramyl dipeptide after coupling with luteinizing hormone-releasing hormone. Riveau G; Hosmalin A; Carelli C; Lefrancier P; Chedid L J Leukoc Biol; 1988 Nov; 44(5):448-54. PubMed ID: 3053952 [TBL] [Abstract][Full Text] [Related]
10. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP. Leclerc C; Juy D; Bourgeois E; Chedid L Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275 [No Abstract] [Full Text] [Related]
11. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Ogawa T; Kotani S; Shimauchi H Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372 [TBL] [Abstract][Full Text] [Related]
12. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture. Dewhirst FE Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of fluorescent muramyl dipeptide congeners. 2. Hiebert CK; Kopp WC; Richerson HB; Barfknecht CF J Med Chem; 1988 Oct; 31(10):2022-4. PubMed ID: 3172138 [TBL] [Abstract][Full Text] [Related]
14. Structural requirements for the induction of "immunological castration" by linear monomeric LHRH-lys-MDP administered in saline. Hosmalin A; Carelli C; Gaillard J; Lefrancier P; Drobecq H; Leclerc C; Amar O; Audibert F; Chedid L Clin Immunol Immunopathol; 1987 Dec; 45(3):447-60. PubMed ID: 3315339 [TBL] [Abstract][Full Text] [Related]
15. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens. Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response. Lowy I; Theze J; Chedid L J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289 [TBL] [Abstract][Full Text] [Related]
17. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies. Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and fast-atom-bombardment-mass spectrometry of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP). Phillips LR; Nishimura O; Fraser BA Carbohydr Res; 1984 Sep; 132(2):275-86. PubMed ID: 6488211 [TBL] [Abstract][Full Text] [Related]
19. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins. Leclerc C; Audibert F; Chedid L Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan. Chang YH; Pearson CM; Chedid L J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]